Abbott Laboratories
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
36.01%
Market Cap
129.83 Bil.
P/E Ratio
33.69
Dividend Yield
1.92 %
Earnings per Share
3.30 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 94.91 Bil. | 31.13 Bil. | 23.29 | +27.43 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 75 G | 0 Units |
| PRICE DETERMINATION TIME | 06/03/2026 / 09:56:36 PM | |
| DAILY VOLUME (UNITS) | 1,643 | |
| DAILY HIGH / LOW | 75.44 | 74.52 |
| PREV. DAY'S PRICE | 74.54 | (06/02) |
| CHANGE DAY BEFORE | +0.46 | 0.62 % |
| 52 WEEK HIGH / LOW | 119.2 (06/25) | 69.64 (05/11) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 5.18 | 4.70 | 3.30 | 7.06 | 3.02 |
| DIVIDENDS PER SHARE | 2.32 | 2.16 | 2.13 | 2.07 | 1.92 |
| DIVIDEND YIELD IN % | - | - | 1.92 % | 1.98 % | 1.89 % |
| DIVIDEND GROWTH IN % | - | - | 2.73 % | 7.63 % | 5.37 % |
| PRICE - EARNINGS RATIO | 14.28 | 15.75 | 33.69 | 14.81 | 33.77 |
| PRICE - BOOK RATIO | - | - | 4.17 | 4.11 | 4.94 |
| PRICE - SALES RATIO | - | - | 4.94 | 4.71 | 4.80 |
| PRICE - CASH FLOW RATIO | - | - | 22.89 | 23.10 | 26.51 |
Master Data
| WKN | 850103 |
| ISIN | US0028241000 |
| SYMBOL | ABL |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Abbott Laboratories |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 1.74 Bil. |
| MARKET CAPITALISATION | 129.83 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.24 % | -3.55 % | -23.74 % | -32.73 % | -36.01 % | -23.31 % | -14.87 % | -29.32 % |
| HIGH | 75.50 | 76.96 | 98.26 | 110.38 | 119.20 | 134.10 | 134.10 | 110.38 |
| LOW | 73.10 | 69.64 | 69.64 | 69.64 | 69.64 | 69.64 | 69.64 | 69.64 |
Dividend
per share
Company profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Structured products for Abbott Laboratories
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.